At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 42 enrolled
Drug / intervention
ReSTOR +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Visual Outcomes of Subjects Bilaterally Implanted With ReSTOR Aspheric +4 vs. Tecnis Multifocal Intraocular Lens (IOL) or Acri.LISA IOL
In Brief
A Phase 4 clinical trial evaluating ReSTOR, Tecnis, and 1 other intervention for Cataract. Completed, enrolled 42 participants across 1 site.
Detailed Summary
This is a study to compare visual outcomes of subjects bilaterally implanted w/ReSTOR to subjects bilaterally implanted with the Tecnis Multifocal Intraocular Lens (IOL) or Acri.LISA IOL
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2007
First PostedJul 2008
Primary CompletionOct 2008
TodayJul 2026
First PostedJul 24, 2008
Enrollment StartJul 1, 2007
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.9 years ago
Interventions
ReSTORdevice
Implantation of the ReSTOR Aspheric +4 (SN6AD3) multifocal intraocular lens (IOL)
Tecnisdevice
Implantation with the Tecnis multifocal (ZM900) intraocular lens (IOL)
Acri.LISAdevice
Implantation with the Acri.LISA 366D multifocal intraocular lens (IOL)